Copyright
©The Author(s) 2025.
World J Clin Oncol. Jan 24, 2025; 16(1): 94813
Published online Jan 24, 2025. doi: 10.5306/wjco.v16.i1.94813
Published online Jan 24, 2025. doi: 10.5306/wjco.v16.i1.94813
Table 1 Clinical features of patients in this study
Discovery cohort | Validation cohort | Statistical method | P value | |
Prognostic model | ||||
(n = 262) | (n = 113) | |||
Survival time in days | Wilcoxon | 0.5446 | ||
Median (IQR) | 1012 (547, 1712) | 1032 (394, 1562) | ||
Alive | χ2 test | 0.5337 | ||
Yes | 104 (39.69) | 41 (36.28) | ||
No | 158 (60.31) | 72 (63.72) | ||
Immunotherapy efficacy model | ||||
(n = 18) | (n = 8) | |||
Sensitivity to immunotherapy | Fisher’s exact | 0.3945 | ||
Yes | 9 (50.00) | 2 (25.00) | ||
No | 9 (50.00) | 6 (75.00) |
Table 2 Overall performance of the ovarian cancer prognostic model
Discovery cohort | Validation cohort | |
AUC | 0.7268 | 0.6475 |
AUC 95%CI | 0.7258-0.7278 | 0.6466-0.6484 |
Table 3 Performance of the ovarian cancer prognostic model when truncated at 1 year, 2 years, and 3 years
Discovery cohort | Validation cohort | |||||
1 year | 2 years | 3 years | 1 year | 2 years | 3 years | |
AUC | 0.7597 | 0.7734 | 0.7461 | 0.6827 | 0.725 | 0.7087 |
AUC 95%CI | 0.6252-0.8942 | 0.6908-0.8560 | 0.6789-0.8134 | 0.5114-0.8541 | 0.6128-0.8373 | 0.6126-0.8049 |
Specificity | 0.7869 | 0.9481 | 0.9022 | 0.7451 | 0.7931 | 0.7895 |
Sensitivity | 0.6667 | 0.58 | 0.5897 | 0.6364 | 0.6538 | 0.6216 |
Accuracy | 0.7786 | 0.8779 | 0.8092 | 0.7345 | 0.7611 | 0.7345 |
NPV | 0.9697 | 0.9054 | 0.8384 | 0.95 | 0.8846 | 0.8108 |
PPV | 0.1875 | 0.725 | 0.7188 | 0.2121 | 0.4857 | 0.5897 |
P value, goodness of fit | 0.6699 | 0.6304 | 0.4325 | 0.0826 | 0.1042 | 0.1084 |
Table 4 Overall performance of the ovarian cancer immunotherapy efficacy model
Discovery cohort | Validation cohort | |
AUC | 0.9444 | 0.9167 |
AUC 95%CI | 0.8333-1.0000 | 0.6667-1.0000 |
Specificity | 1.0000 | 0.8333 |
Sensitivity | 0.8889 | 1.0000 |
Accuracy | 0.9444 | 0.8750 |
NPV | 0.9000 | 1.0000 |
PPV | 1.0000 | 0.6667 |
P value, goodness of fit | 0.3708 | 0.1175 |
- Citation: Tang ZJ, Pan YM, Li W, Ma RQ, Wang JL. Unlocking the future: Mitochondrial genes and neural networks in predicting ovarian cancer prognosis and immunotherapy response. World J Clin Oncol 2025; 16(1): 94813
- URL: https://www.wjgnet.com/2218-4333/full/v16/i1/94813.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i1.94813